Results 71 to 80 of about 24,646 (191)
Background Enoxaparin and Fondaparinux are potential anticoagulants which are used peri-operatively in the management of patients with Acute Coronary Syndrome (ACS).
Pravesh Kumar Bundhun +2 more
doaj +1 more source
Recurrent thrombosis rescued by fondaparinux in high‐risk patients: A case series
Background Recurrent thrombosis treatment options are limited when anticoagulation with dose escalation of low molecular weight heparin or unfractionated heparin fail. Fondaparinux is a pure, synthetic pentasaccharide that consists of heparin's essential
Mégane Tanguay, Chantal Séguin
doaj +1 more source
Produktprofil von Pentasaccharid (Fondaparinux-Natrium)
ZusammenfassungMit dem Pentasaccharid (INN: Fondaparinux) wird demnächst der erste Vertreter einer neuen Substanzklasse von selektiven Faktor-Xa-Inhibitoren zur Verfügung stehen.
R. M. Bauersachs
core +1 more source
ABSTRACT Background According to global projections, by the year 2050, ischemic heart disease will remain the leading cause of cardiovascular deaths with hypertension as a leading modifiable risk factor for mortality. Improving quality care for patients with acute myocardial infarction (MI) is associated with improved outcomes. Aims There is inadequate
Banaz Sadiq Elias +2 more
wiley +1 more source
BACKGROUND Life-threatening heparin-induced thrombocytopenia (HIT) is treated with the alternative nonheparin anticoagulants argatroban, lepirudin, or danaparoid. Frequently, the pentasaccharide fondaparinux is used off-label.
Schindewolf, Marc +29 more
core +1 more source
Anticoagulation Stewardship Around the World: A Global Survey of the Current Landscape. ABSTRACT Background Little is known about the familiarity and implementation of anticoagulation (AC) stewardship on a global scale. Therefore, we aimed to identify current AC stewardship patterns globally.
Nancy L. Shapiro +2 more
wiley +1 more source
Fondaparinux - data on efficacy and safety in special situations
New anticoagulants promise to have better efficacy, more safety and/or a better manageability than traditional anticoagulants. However, knowledge is limited regarding special situations such as renal insufficiency, obesity, pregnancy, long-term therapy ...
Michael Haslauer +5 more
core +1 more source
Importance: The use of anticoagulant therapy with heparins decreased mortality in hospitalized patients with severe coronavirus disease 2019 (COVID-19). Even if enoxaparin and fondaparinux have the same clinical indication for venous thromboembolism (VTE)
Vincenzo Russo +13 more
doaj +1 more source
Abstract Background Previous observational studies have reported an increased risk of venous thromboembolism (VTE) among non‐steroidal anti‐inflammatory drug (NSAID) users compared with non‐users. However, these studies may have been subject to bias due to unmeasured confounders related to patient conditions requiring NSAIDs.
Yuichiro Matsuo +2 more
wiley +1 more source
The flow diagram of study. ABSTRACT Surgery continues to remain the most effective treatment for spinal metastasis (SM). As the number of surgeries continues to grow, the need for consensus guidelines for optimal perioperative care is imperative. Enhanced recovery after surgery (ERAS) protocols were created for this purpose. The objective of this study
Fanjie Li +11 more
wiley +1 more source

